Hyperion DeFi, Inc. (HYPD) company profile

Hyperion DeFi, Inc. operates as a digital asset treasury company focused on accumulating and deploying Hyperliquid’s native token, HYPE, while maintaining an ophthalmic technology business. The company provides shareholders with exposure to the decentralized finance ecosystem by staking tokens, operating a joint network validator node, and providing liquidity and token inventory under service agreements to decentralized protocols. In addition, the firm develops the Optejet user-filled device, a precision ocular liquid delivery system designed to administer front-of-the-eye medications with reduced dosage volume and improved compliance compared to traditional eye drops.

The company conducts its corporate and development activities from its executive headquarters in Laguna Hills, California. It operates with a team of nine full-time employees, engaging specialized consultants and infrastructure contractors to assist in running its validator operations, managing decentralized finance interactions, and pursuing regulatory clearance and commercialization transactions for its medical delivery device.

Summary of the business section of Hyperion DeFi's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

“The initial public offering price of our common stock is $10.00 per share.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

“As of December 31, 2025, we had nine employees, all of which are full-time employees.”